Â鶹´«Ã½

Feature Channels: Alzheimer's and Dementia

Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 27-Nov-2024 4:00 PM EST Released to reporters: 21-Nov-2024 2:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2024 4:00 PM EST The Â鶹´«Ã½ PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Â鶹´«Ã½: University Hospitals Only Health System in Northeast Ohio Offering FDA-Approved KISUNLAâ„¢ for Treatment of Alzheimer’s Disease
Released: 20-Nov-2024 10:00 AM EST
University Hospitals Only Health System in Northeast Ohio Offering FDA-Approved KISUNLA™ for Treatment of Alzheimer’s Disease
University Hospitals Cleveland Medical Center

University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer’s disease. UH is the only health system in Northeast Ohio currently offering these infusion treatments.

Â鶹´«Ã½: Listening for Early Signs of Alzheimer’s Disease #ASA187
11-Nov-2024 9:20 AM EST
Listening for Early Signs of Alzheimer’s Disease #ASA187
Acoustical Society of America (ASA)

People with Alzheimer’s exhibit a loss of motor control along with cognitive decline, and one of the earliest signs of this decay can be spotted in involuntary eye movements known as saccades. These quick twitches of the eyes in Alzheimer’s patients are often slower, less accurate, or delayed compared to those in healthy individuals.

   
Released: 19-Nov-2024 1:50 PM EST
How Educational Attainment May Impact Memory and Dementia Risk Later in Life
Institute for Health, Health Care Policy and Aging Research at Rutgers University

Rutgers Institute for Health researcher lead a study examining the impact of educational attainment on cognition later in life.

   
access_time Embargo lifts in 2 days
This news release is embargoed until 25-Nov-2024 3:00 PM EST Released to reporters: 19-Nov-2024 12:25 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 25-Nov-2024 3:00 PM EST The Â鶹´«Ã½ PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Nov-2024 12:00 PM EST
Combating Dementia with Film, Communication and Emotion
Universite de Montreal

A doctoral student in speech-language pathology at Université de Montréal is testing the use of audiovisual content to support communication in people with dementia.

Â鶹´«Ã½: dementia-hero-940x529.jpg
Released: 18-Nov-2024 12:55 PM EST
How to Care for a Loved One with Dementia
University of Miami

More than 11 million Americans are tasked with the responsibility of taking care of someone with cognitive decline.

Â鶹´«Ã½: New Pathways for Alzheimer's Prevention
Released: 15-Nov-2024 12:00 PM EST
New Pathways for Alzheimer's Prevention
University of Delaware

A new study from the University of Delaware will look at Alzheimer's disease (AD) and examine how changes in arterial stiffness and brain tissue in midlife adults could contribute to cognitive decline. The study aims to pinpoint early risk factors and explore preventive interventions.

Â鶹´«Ã½: 1920_virtual-reality-cedars-sinai.jpg?10000
Released: 15-Nov-2024 11:10 AM EST
November Research Tip Sheet
Cedars-Sinai

Cedars-Sinai has published a summary highlighting its research advances for November 2024.

Released: 14-Nov-2024 3:40 PM EST
MSU Researchers Receive $4m NIH Grant to Study Dementia Risks
Michigan State University

MSU researchers receive $4M NIH grant to study dementia risks

Released: 14-Nov-2024 2:05 PM EST
New Drug Targets for Alzheimer’s Identified From Cerebrospinal Fluid
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression. The proteins were gathered from cerebrospinal fluid and are a good proxy for activity in the brain. Several of them may be potential targets for therapies.

Released: 14-Nov-2024 12:10 PM EST
UC Irvine-led Study Reveals New Insights Into How We Navigate Space and Store Memories
University of California, Irvine

Irvine, Calif., Nov. 14, 2024 — Researchers led by the University of California, Irvine are the first to reveal how two neural circuits located in the brain’s retrosplenial cortex are directly linked to spatial navigation and memory storage. This discovery could lead to more precise medical treatments for Alzheimer’s disease and other cognitive disorders by allowing them to target pathway-specific neural circuits.

Released: 13-Nov-2024 9:30 PM EST
McMaster University Researchers Uncover Potential Treatment for Rare Genetic Disorders
McMaster University

In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and spinal cord. After years of investigating the diseases’ underlying mechanisms, the research team has identified an existing FDA-approved drug that could significantly improve quality of life for affected patients and their families.

Â鶹´«Ã½: New Award Advances Sanders-Brown Director’s Research on Inflammation’s Role in Alzheimer’s
Released: 13-Nov-2024 2:40 PM EST
New Award Advances Sanders-Brown Director’s Research on Inflammation’s Role in Alzheimer’s
University of Kentucky

The University of Kentucky Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., hopes to shed light on how specific brain cells may contribute to the progression of Alzheimer’s disease, paving the way for potential new therapeutic approaches.Van Eldik recently received a three-year, $300,000 award from the BrightFocus Foundation to support her research project, “Relationship between astrocyte p38 MAPK, neuroinflammation, and Alzheimer pathology.

Â鶹´«Ã½: 1920_heatlthy-aging-cedars-sinai.jpg?10000
Released: 7-Nov-2024 5:30 PM EST
Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024
Cedars-Sinai

Experts on healthy aging from Cedars-Sinai’s growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America’s (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.

Â鶹´«Ã½: ASA Press Conference Schedule for Monday, Nov. 18 #ASA187
Released: 7-Nov-2024 12:50 PM EST
ASA Press Conference Schedule for Monday, Nov. 18 #ASA187
Acoustical Society of America (ASA)

The Acoustical Society of America will host two virtual press conferences Monday, Nov. 18. ASA’s 187th meeting will be held online, and reporters are invited to join technical sessions Nov. 19-21. Media are invited to join the virtual press conferences for presentations on dinosaur acoustics, using camp stove waste for new outdoor power sources, predicting Alzheimer’s with in-ear microphones, and more.

   
31-Oct-2024 3:10 PM EDT
Sleepiness During the Day May Be Tied to Pre-dementia Syndrome
American Academy of Neurology (AAN)

Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a study published in the November 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 5-Nov-2024 11:25 AM EST
Trend of Antibiotic Resistance in Alzheimer’s Needs Examining
Alzheimer's Center at Temple University Lewis Katz School of Medicine

A review article entitled “Prevalence of Antibiotic Resistance in Older Adults and Alzheimer’s Disease Patients: A Systematic Review and Meta-Analysis,†is now published in the Journal Alzheimer’s Disease Reports.

Released: 4-Nov-2024 3:20 PM EST
UW–Madison researchers find persistent problems with AI-assisted genomic studies
University of Wisconsin–Madison

University of Wisconsin–Madison researchers are warning that artificial intelligence tools gaining popularity in the fields of genetics and medicine can lead to flawed conclusions about the connection between genes and physical characteristics, including risk factors for diseases like diabetes.The faulty predictions are linked to researchers’ use of AI to assist genome-wide association studies.



close
2.65199